Radiopharm Theranostics L... (RADX)
NASDAQ: RADX
· Real-Time Price · USD
6.20
0.14 (2.31%)
At close: Oct 03, 2025, 3:55 PM
6.29
1.45%
After-hours: Oct 03, 2025, 05:41 PM EDT
2.31% (1D)
| Bid | 5.51 |
| Market Cap | 7.99M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -3.47 |
| PE Ratio (ttm) | -1.79 |
| Forward PE | -1 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 6.2 |
| Volume | 5,329 |
| Avg. Volume (20D) | 29,955 |
| Open | 6.24 |
| Previous Close | 6.06 |
| Day's Range | 6.00 - 6.30 |
| 52-Week Range | 3.50 - 50.82 |
| Beta | 0.91 |
| Ex-Dividend Date | n/a |
About RADX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RADX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RADX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+4.9%
Radiopharm Theranostics shares are trading higher ...
Unlock content with
Pro Subscription
4 months ago
+11.18%
Radiopharm Theranostics shares are trading higher after the company announced preclinical data from studies with the Lu177-B7H3-monoclonal antibody RV01.